JPRN-UMIN000009411已完成未知
The efficacy of rituximab for children with refractory nephrotic syndrome - Rituximab for children with refractory nephrotic syndrome
Department of Pediatrics, Kobe University Graduate School of Medicine0 个研究点目标入组 20 人开始时间: 2012年12月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 1years-old 至 30years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •steroid resistant nephrotic syndrome
研究者
相似试验
招募中
3 期
Early rituximab treatment in children with idiopathic nephrotic syndrome Eng. ERICONS - Early RITUXIMAB in Childhood Onset Nephrotic Syndrome2024-515058-26-00Medical University Of Gdansk60
已完成
不适用
Rituximab in pediatric rheumatic diseases: 2 years follow up for immunological long-term effects using a standardized screening and safety protocol.M08.0M32.1Systemic lupus erythematosus with organ or system involvementJuvenile rheumatoid arthritisDRKS00020514(Non-profit) Verein: Hilfe für das rheumakranke Kind e.V.21
进行中（未招募）
1 期
Efficacy and safety of rituximab in the treatment of good prognosis microscopic polyangiitisEUCTR2018-000637-12-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)106
已完成
2 期
The efficacy of rituximab for recalcitrant Pemphigus Vulgaris in the patients of Razi hospital from 2007 to 2011Pemphigus vulgaris.Pemphigus vulgarisIRCT201111022704N2Vice-chancellor for Research of Tehran University of Medical Sciences40
已完成
不适用
A study of the efficacy and safety to rituximab in treating adult onset refractory nephrotic syndromeRefractory nephrotic syndromeJPRN-UMIN000021143Fujita Health University School of Medicine, Department of Nephrology10